82 related articles for article (PubMed ID: 8538903)
1. [Variations in microalbuminuria in essential hypertension treated with ACE inhibitors, calcium antagonists and their association].
Abate D; Cafà R; Castellino AR; Maligno C; Sorrusca F; Abate FC
Minerva Cardioangiol; 1995; 43(7-8):303-7. PubMed ID: 8538903
[TBL] [Abstract][Full Text] [Related]
2. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
[No Abstract] [Full Text] [Related]
3. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
Rahn KH
Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
[TBL] [Abstract][Full Text] [Related]
4. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
5. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
[TBL] [Abstract][Full Text] [Related]
6. Nitrendipine and enalapril in the treatment of diabetic hypertensive patients with microalbuminuria.
Piñol C; Cobos A; Cases A; Esmatges E; Soler J; Closas J; Pascual R; Planas J
Kidney Int Suppl; 1996 Jun; 55():S85-7. PubMed ID: 8743519
[TBL] [Abstract][Full Text] [Related]
7. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Bakris GL; Toto RD; McCullough PA
J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].
Nitschmann S
Internist (Berl); 2006 Feb; 47(2):199-200; discussion 200. PubMed ID: 16416298
[No Abstract] [Full Text] [Related]
10. Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension.
Ruilope LM; Alcázar JM; Hernández E; Praga M; Lahera V; Rodicio JL
Kidney Int Suppl; 1994 Feb; 45():S171-3. PubMed ID: 7908997
[No Abstract] [Full Text] [Related]
11. ACE inhibitors and calcium channel blockers: patterns of use and associations with mortality in type 1 diabetes.
Sobolewski BA; Zgibor JC; Orchard TJ
Diabetes Res Clin Pract; 2004 Jul; 65(1):37-43. PubMed ID: 15163476
[TBL] [Abstract][Full Text] [Related]
12. Class effect of angiotensin-converting enzyme inhibitors on prevention of myocardial infarction.
Sauer WH; Baer JT; Berlin JA; Kimmel SE
Am J Cardiol; 2004 Nov; 94(9):1171-3. PubMed ID: 15518614
[TBL] [Abstract][Full Text] [Related]
13. When hypertension and diabetes coexist: strategies for cardiorenal protection.
Weber MA
Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
[TBL] [Abstract][Full Text] [Related]
14. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C;
Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
[TBL] [Abstract][Full Text] [Related]
15. Fixed dose combinations of ACE inhibitors.
Rangoonwala B; Schulz W; Bauer B
Br J Clin Pract; 1996 Dec; 50(8):454-65. PubMed ID: 9039718
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of hypertension--what treatment for what patients?].
Zidek W; Tepel M; van der Giet M
MMW Fortschr Med; 2004 May; 146(22):31-4. PubMed ID: 15373106
[TBL] [Abstract][Full Text] [Related]
17. Adult hypertension: reducing cardiovascular morbidity and mortality.
Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
[TBL] [Abstract][Full Text] [Related]
18. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of hypertension in the elderly].
Hohage H; Gerhardt U; Suwelack BM
Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
[No Abstract] [Full Text] [Related]
20. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors.
Rollins G
Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699
[No Abstract] [Full Text] [Related]
[Next] [New Search]
